Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thin basement membrane nephropathy.

Judy Savige1, Kesha Rana, Stephen Tonna

  • 1University of Melbourne, Department of Medicine, Austin and Repatriation Medical Centre, Heidelberg, Victoria, Australia. jsavige@austin.unimelb.edu.au

Kidney International
|September 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autosomal Dominant Alport Syndrome.

Journal of the American Society of Nephrology : JASN·2026
Same author

Gene-disease relationships for glomerular phenotypes: expert recommendations from ClinGen.

Nature reviews. Nephrology·2026
Same author

The population frequency of predicted pathogenic genetic variants in commonly affected CAKUT genes in the general population.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Monogenic kidney disease and monogenic diabetes are present in renal clinic patients with non-genetic diagnoses.

Scientific reports·2026
Same author

Caring for Australians and New ZealandeRs with kidney Impairment guideline commentary on kidney disease: improving global outcomes 2025 guidelines for diagnosis and management of autosomal polycystic kidney disease.

Internal medicine journal·2026
Same author

Alport: Renaming an Extended Clinical Spectrum.

Journal of the American Society of Nephrology : JASN·2026

Thin basement membrane nephropathy (TBMN) is a common cause of persistent glomerular bleeding. While usually benign, some adults may develop kidney impairment, potentially linked to genetic factors or other kidney diseases.

Area of Science:

  • Nephrology
  • Genetics
  • Pathology

Background:

  • Thin basement membrane nephropathy (TBMN) affects at least 1% of the population, causing persistent glomerular bleeding (hematuria).
  • Individuals with TBMN typically present with minimal proteinuria, normal renal function, uniformly thinned glomerular basement membrane (GBM), and a family history of hematuria.
  • While often benign, some adults with TBMN may experience significant proteinuria or renal impairment, necessitating further investigation.

Purpose of the Study:

  • To summarize the clinical presentation, genetic underpinnings, and diagnostic considerations for thin basement membrane nephropathy (TBMN).
  • To differentiate TBMN from other glomerular diseases like IgA nephropathy and Alport syndrome.
  • To discuss the implications of genetic mutations in COL4A3/COL4A4 and their role in TBMN and related conditions.

Related Experiment Videos

Main Methods:

  • Review of existing literature on thin basement membrane nephropathy (TBMN).
  • Analysis of clinical features, renal biopsy findings, and genetic associations in TBMN.
  • Comparison of TBMN with IgA disease and X-linked Alport syndrome.

Main Results:

  • Approximately 40% of TBMN families show hematuria linked to the COL4A3/COL4A4 locus, with numerous mutations identified.
  • Some TBMN cases may represent carriers of autosomal-recessive Alport syndrome.
  • Renal impairment in TBMN can be attributed to secondary focal segmental glomerulosclerosis (FSGS), IgA glomerulonephritis, or coincidental diseases.

Conclusions:

  • TBMN is a prevalent cause of hematuria, usually with a benign prognosis.
  • Genetic factors, particularly COL4A3/COL4A4 mutations, play a significant role in TBMN and related disorders.
  • Renal biopsy is reserved for atypical TBMN cases or when IgA disease or X-linked Alport syndrome cannot be excluded clinically.